Higèa announces the acquisition of 80% of Biomedicale S.r.l.

Higèa S.p.A., a company controlled by Althea (formerly Pantheon Healthcare Group), has finalised the acquisition of the 80% of Biomedicale S.r.l., a company owned by Zephyro S.p.A., an Italian company listed at AIM market of “Borsa Italiana” and operating in the healthcare and facility management industries.

With this important operation, Higèa S.p.A., that counts more than 400 employees, a turnover of approx. 100 Millions of Euro and a portfolio with more than 100 Italian and European health facilities, consolidates its leadership in the healthcare engineering services.

This acquisition has a key role in the development process of Althea (formerly Pantheon Healthcare Group), which includes, besides Higèa, other companies such as Asteral, MESA, Ed Sloan & Associates, Sigil, Spintech and MVS.

The Group, founded in August 2014, is at its thirteenth acquisition conducted in several countries, with a focus in European market.

Alessandro Dogliani, Group CEO declares, “An operation in line with the strategies for the growth of Higèa and Althea that will allow us to strengthen our biomedical integrated services, and, thanks to our know-how, to develop the management processes, improving the results”.

This operation, performed a few weeks after the acquisition of Iteon Tecnologie S.r.l. biomedical division, was achieved with the support of Ernst & Young, Giliberti Pappalettera e Triscornia and Maisto e Associati.

HFMA Provider Conference 2016

Althea enjoyed another successful show at the Healthcare Finance Management Association (HFMA) Annual Provider Conference, which took place at the Chesford Grange Hotel, Warwickshire on 7th and 8th July 2016 and had a theme of ‘Creating Synergy’.

Althea recognises the importance of creating synergy within the NHS in order to support the radical changes it is facing as part of delivering the 5 year forward view, where it states that “Trusts will need to procure capital assets more efficiently, consider alternative methods of securing assets such as managed equipment services”. Asteral Select offers a bespoke, vendor-independent managed service with flexible arrangements to meet specific needs. Our service is proven to deliver measurable cost and efficiency savings.

Finance Directors and finance departments have a key role to play in this future, the conference hosted speakers who explained the models, shared the progress to date and featured real life case studies from those increasing effectiveness of healthcare for their populations. The exhibition allowed Asteral to interact with the delegates and showcase the beneficial features of Asteral Select.

The event saw around 35 exhibitors showcasing a range of different products and services to the 140 delegates who attended the two-day event.

The NHS England 5 Year Forward View can be found at here.